Search

Your search keyword '"A. Nicolas"' showing total 4,633 results

Search Constraints

Start Over You searched for: Author "A. Nicolas" Remove constraint Author: "A. Nicolas" Journal blood Remove constraint Journal: blood
4,633 results on '"A. Nicolas"'

Search Results

1. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL

2. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

3. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

4. Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias

5. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis

6. Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia

7. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

8. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

9. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

11. Hemostasis defects underlying the hemorrhagic syndrome caused by mammarenaviruses in a cynomolgus macaque model

12. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study

13. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma

15. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death

16. Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors

17. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition

18. DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

19. Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms

21. Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

22. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

24. A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia

25. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation

26. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

27. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target

29. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

30. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

31. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

32. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL

33. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

34. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

36. Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

37. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal

38. Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis

39. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

41. High frequency of clonal hematopoiesis in Erdheim-Chester disease

43. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

45. FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus

46. Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia

47. Secondary Acute Myeloid Leukemia from a Previous Chronic Myeloproliferative Neoplasm: A Study of Grelam-Chile Concerning Chilean Patients on Behalf of AML Pethema Registry

48. Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry

49. Clonal Dynamics of FLT3-ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin

50. Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders

Catalog

Books, media, physical & digital resources